Phibro Animal Health | PAHC - Operating Expenses


Phibro Animal Health reported $361.83M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Align Technology USD 862.03M 39.18M Mar/2026
ANI Pharmaceuticals USD 562.3M 344.37M Mar/2026
Aurora Cannabis CAD 129.98M 16.05M Dec/2025
Bristol-Myers Squibb USD 20.07B 11.77B Mar/2026
Canopy Growth CAD 87.2M 6.22M Dec/2025
Corcept Therapeutics USD 214.5M 16.87M Mar/2026
Eli Lilly USD 10.02B 285M Mar/2026
Henry Schein USD 3.17B 77M Mar/2026
Idexx Laboratories USD 778.23M 3.26M Mar/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Merck USD 18.17B 8.01B Mar/2026
Nektar Therapeutics USD 40.9M 44.19M Dec/2025
Pacira USD 172.75M 20.93M Mar/2026
Phibro Animal Health USD 361.83M 29.47M Mar/2026
Prestige Brands USD 206.12M 5.17M Mar/2026
Supernus Pharmaceuticals USD 1.08B 879.06M Mar/2026
Zoetis USD 3.23B 1.68B Mar/2026